Clinical Trial Update: A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma. [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 study of rituximab (MabThera) added to standard chemotherapy in patients with previously untreated mantle cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• MabThera (Rituximab) (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-11-26